Ethical issues in cancer genetics: I 1) whose information is it?

Autor: Schneider KA, Chittenden AB, Branda KJ, Keenan MA, Joffe S, Patenaude AF, Reynolds H, Dent K, Eubanks S, Goldman J, Leroy B, Warren NS, Taylor K, Vockley CW, Garber JE

Publikováno v: Journal of Genetic Counseling; Dec2006, Vol. 15 Issue 6, p491-503, 13p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.

Autor: Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. matthew_yurgelun@dfci.harvard.edu.; Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA. matthew_yurgelun@dfci.harvard.edu., Chittenden AB; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Morales-Oyarvide V; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA., Dunne RF; Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA., Kozak MM; Department of Radiation Oncology, Stanford Cancer Institute, Stanford, CA, USA., Qian ZR; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Welch MW; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Da Silva A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Bui JL; Department of Radiation Oncology, Stanford Cancer Institute, Stanford, CA, USA., Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Li T; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Li W; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Masuda A; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Gu M; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Bullock AJ; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA., Chang DT; Department of Radiation Oncology, Stanford Cancer Institute, Stanford, CA, USA., Clancy TE; Department of Surgery, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA., Linehan DC; Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA., Findeis-Hosey JJ; Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA., Doyle LA; Department of Pathology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA., Thorner AR; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA, USA., Ducar MD; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA, USA., Wollison BM; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA, USA., Khalaf N; Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA., Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA., Syngal S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA., Aguirre AJ; Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA, USA., Meyerson ML; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Fuchs CS; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Ogino S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Pathology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA., Hornick JL; Department of Pathology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA., Hezel AF; Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA., Koong AC; Department of Radiation Oncology, Stanford Cancer Institute, Stanford, CA, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nowak JA; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA.

Publikováno v: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2019 Jan; Vol. 21 (1), pp. 213-223. Date of Electronic Publication: 2018 Jul 02.